Medical Department III - Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, Germany.
Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.
Front Endocrinol (Lausanne). 2023 Aug 8;14:1181002. doi: 10.3389/fendo.2023.1181002. eCollection 2023.
Over the past 50 years, the number of overweight/obese people increased significantly, making obesity a global public health challenge. Apart from rare monogenic forms, obesity is a multifactorial disease, most likely resulting from a concerted interaction of genetic, epigenetic and environmental factors. Although recent studies opened new avenues in elucidating the complex genetics behind obesity, the biological mechanisms contributing to individual's risk to become obese are not yet fully understood. Non-genetic factors such as eating behaviour or physical activity are strong contributing factors for the onset of obesity. These factors may interact with genetic predispositions most likely epigenetic mechanisms. Epigenome-wide association studies or methylome-wide association studies are measuring DNA methylation at single CpGs across thousands of genes and capture associations to obesity phenotypes such as BMI. However, they only represent a snapshot in the complex biological network and cannot distinguish between causes and consequences. Intervention studies are therefore a suitable method to control for confounding factors and to avoid possible sources of bias. In particular, intervention studies documenting changes in obesity-associated epigenetic markers during lifestyle driven weight loss, make an important contribution to a better understanding of epigenetic reprogramming in obesity. To investigate the impact of lifestyle in obesity state specific DNA methylation, especially concerning the development of new strategies for prevention and individual therapy, we reviewed 19 most recent human intervention studies. In summary, this review highlights the huge potential of targeted interventions to alter disease-associated epigenetic patterns. However, there is an urgent need for further robust and larger studies to identify the specific DNA methylation biomarkers which influence obesity.
在过去的 50 年中,超重/肥胖人群的数量显著增加,使肥胖成为全球公共卫生挑战。除了罕见的单基因形式外,肥胖是一种多因素疾病,最有可能是遗传、表观遗传和环境因素协同作用的结果。尽管最近的研究为阐明肥胖背后复杂的遗传机制开辟了新途径,但导致个体肥胖风险的生物学机制尚不完全清楚。非遗传因素,如饮食行为或体力活动,是肥胖发生的重要促成因素。这些因素可能与遗传易感性(最有可能是表观遗传机制)相互作用。全基因组关联研究或全甲基化组关联研究测量数千个基因中单个 CpG 处的 DNA 甲基化,并捕获与肥胖表型(如 BMI)相关的关联。然而,它们仅代表复杂生物网络中的一个快照,无法区分因果关系。因此,干预研究是控制混杂因素和避免可能的偏倚的合适方法。特别是,记录生活方式驱动的体重减轻过程中与肥胖相关的表观遗传标记变化的干预研究,对更好地理解肥胖中的表观遗传重编程做出了重要贡献。为了研究生活方式对肥胖状态特异性 DNA 甲基化的影响,特别是关于预防和个体化治疗新策略的发展,我们回顾了 19 项最新的人类干预研究。总之,本综述强调了靶向干预改变与疾病相关的表观遗传模式的巨大潜力。然而,迫切需要进一步进行更强大和更大规模的研究,以确定影响肥胖的特定 DNA 甲基化生物标志物。